Please assess the completion status of the following clinical trial:

Trial Title: Scandinavian Intensive Care Unit (ICU) Glutamine Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* admission to the ICU~* decision to give the patient full nutrition~* APACHE II score \> 10 at admission~* age 18-85 years~Exclusion Criteria:~* readmission to the ICU after a previous ICU-stay in which the patient has been included into the study~* subjects with any condition which in the opinion of the attending physician makes the subject unsuitable for inclusion~* no informed consent

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Study Arms:
- Glutamine (Type: EXPERIMENTAL): Intravenous glutamine supplementation (0.285 g/kg body weight/24 h)
- Control (Type: PLACEBO_COMPARATOR): saline

Based on this trial design, predict the completion outcome and termination type (if applicable).